Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Dose ITI in Children With Severe and Moderate Hemophilia A With High Titer Inhibitor
NCT03598725Phase 4Unknown
- Sponsor
- Beijing Children's Hospital
- Start
- Jan 2016
- Primary completion
- Dec 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of Factor VIII in hemophilia A, sponsored by Beijing Children's Hospital. Status: unknown.
02
Drugs
Factor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT03598725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03598725.